RecruitingNCT07456397

Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential

Development and Validation of an Artificial Intelligence Platform for the Analysis of Sperm Samples and Prediction of Their Clinical Potential

Sponsor

Fecundis Lab SL

Enrollment

500 participants

Start Date

Mar 18, 2026

Study Type

OBSERVATIONAL

Conditions

Male infertility Infertility (IVF Patients)Reproductive Issues ICSI IVF Outcomes

Summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to develop an artificial intelligence platform for the analysis of sperm samples and prediction of their clinical potential, in 500 semen samples, in an in vitro study over 24 months.

Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Density gradient centrifugation, a medical device called HyperSperm, and others for people with icsi, ivf outcomes, and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.